SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000919574-17-008284
Filing Date
2017-11-20
Accepted
2017-11-20 16:09:40
Documents
1
Period of Report
2017-11-16

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT p7740626.html 3  
1 OWNERSHIP DOCUMENT p7740626.xml 3 5203
  Complete submission text file 0000919574-17-008284.txt   7795
Mailing Address C/O 20 GENESIS CLOSE ANSBACHER HOUSE, 2ND FLOOR, PO BOX 1344 GRAND CAYMAN E9 KY1-1108
Business Address C/O 20 GENESIS CLOSE ANSBACHER HOUSE, 2ND FLOOR, PO BOX 1344 GRAND CAYMAN E9 KY1-1108 212-808-2460
Broadfin Healthcare Master Fund Ltd (Reporting) CIK: 0001511900 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-35921 | Film No.: 171213852

Mailing Address 300 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022 212-808-2463
Broadfin Capital, LLC (Reporting) CIK: 0001511901 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-35921 | Film No.: 171213851

Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Issuer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BROADFIN CAPITAL, LLC 300 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022
Business Address
KOTLER KEVIN (Reporting) CIK: 0001601692 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35921 | Film No.: 171213850